Valuation
- Market cap
- 67,793,000
- Revenue TTM
- $30,256,919
- Net income TTM
- $-2,874,042
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -9.50%
- Debt to equity
- 0.00
Trading
- Volume
- 87,900
- Avg volume
- 32,782
- Day's range
- $2.16 – $2.18
- Shares out
- 31,241,000
- Stochastic %K
- 67%
- Beta
- 0.93
- Analysts
- Hold
- Price target
- $2.10
Company profile
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare...
Show more
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc. operates as a subsidiary of 2025 Acquisition Company, LLC.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 267 225 6263
- Website
- https://forian.com
- Address
- 41 University Drive, Suite 400, Newtown, United States
Latest news
No headlines yet.
